| Investor Relations |
Financial Highlights
Mitsubishi Pharma Corporation and Consolidated Subsidiaries
Millions of yen Thousands of
U.S. dollars
2006 2005 2004 2006
Years ended March 31:
Net sales 
¥ 236,207 ¥ 234,244 ¥ 235,431 $ 2,018,863
Operating income 
36,235 31,049 28,727 309,701
Net income 
20,699 13,172 10,818 176,915
Research and development costs 
47,913 50,482 50,528 409,513
At March 31:
Total assets 
¥ 307,052 ¥ 290,628 ¥ 296,200 $ 2,624,376
Shareholders' equity 
231,541 205,981 197,541 1,978,983
Yen U.S. dollars
Amounts per share:
Net income 
¥ 45.39 ¥ 29.02 ¥ 23.81 $ 0.39
Cash dividends applicable
  to the year 
20.44 10.00 10.00 0.17
Thousands of shares
Common stock issued 
458,435 458,435 458,435   
Note:  Yen amounts are translated into U.S. dollars, for convenience only, at the rate of 117.00 = US$1.00, the approximate exchange rate in effect on March 31, 2006.
 
 
  
AR TOP |

Profile
Financial Highlights
Message from the President
Business results
Establishment of Joint Holding Company
Launch of Joint Holding Company, Mitsubishi Chemical Holdings Corporation, from October 2005
Strengthening Pharmaceutical Business through Joint Holding Company Structure
Meeting Tomorrow’s Challenge in Personalized Medicine
Mid-term Corporate Action Plan
Mid-term Corporate Action Plan — On Target
Maximization of Sales and Marketing Strengths
Optimization of Production and Technology Divisions
Target of Total Cost Reduction Achieved
Increasing the Certainty of Research and Development Results and Establishment of Global Marketing Basis
R&D
Strengthening Research and Development
Product Pipeline
Corporate Social Responsibility
Improving Corporate Governance System
Reinforced Implementation of Compliance
Global Environmental Conservation: a Task for Every Individual
Harmony with Society
Financial Section
Five-Year Summary
Management’s Discussion and Analysis
Balance Sheets
Income Statements
Shareholders’ Equity
Cash Flows
Notes
Auditors’ Report
Corporate Data

Mitsubishi Chemical Holdings Corporation Investor Center
Copyright© Mitsubishi Pharma Corporation. All Rights Reserved.